Nesifin (300 mg+1.25 ml)/5 ml (Emulsion)

Indications

• Constipation
• Hyperacidity with constipation
• Anorectal disorder
• Post-operative constipation
• Constipation associated with chronic cholecystitis
• Hernia

Pharmacology

Dual-relief formulation containing a gentle laxative ingredient and a lubricant which eases the discomfort associated with straining and bowel movement

Dosage & Administration

• Adults: 15-30ml before breakfast or at bedtime
• Children:
  • Over 7 years: 7.5 ml-15 ml at bedtime
  • 3-7 years: 5-10 ml at bedtime
  • The dose may be mixed with milk or half a glass of water if desired
  • Don't take for more than 1 week unless under doctor's supervision

Interaction

Cimetidine, Diuretics, Famotidine and Ranitidine may cause irritation of stomach or bowel

Contraindications

Acute GI conditions like abdominal pain

Side Effects

• Rectal irritation
• Potassium loss (thirst, weakness, nausea and diarrhea)

Pregnancy & Lactation

Can be given to pregnant and lactating mother

Precautions & Warnings

• Renal and hepatic impairment
• Maintain adequate fluid intake

Overdose Effects

There are no reported cases of overdosage

Therapeutic Class

Antacid with laxative action

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children

Related Brands

• Frelax (300 mg+1.25 ml)/5 ml (Emulsion) - beximco-pharmaceuticals-ltd
• Sevelax (300 mg+1.25 ml)/5 ml (Emulsion) - pacific-pharmaceuticals-ltd
• Laxefin (300 mg+1.25 ml)/5 ml (Emulsion) - sharif-pharmaceuticals-ltd
• Duolax (300 mg+1.25 ml)/5 ml (Emulsion) - square-pharmaceuticals-plc
• Magfin (300 mg+1.25 ml)/5 ml (Emulsion) - incepta-pharmaceuticals-ltd